Results

Total Results: 1,636 records

Showing results for "treating".

101. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - Experts commented that this intervention should be used as a last resort in treating patients with … FDA approved once-weekly exenatide in January 2012 for treating T2DM. … FDA had earlier approved it for treating wet age-related macular degeneration and macular edema with … However, longterm, these procedures could reduce the burden of treating diabetes if they prove safe … Although some experts agreed that any new therapy for treating diabetes would be welcome, some saw

102. Disabilities-Quality-Improvement-Outcomes Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_executive.pdf
     October 01, 2012 - effect on the outcome in addition to the effect of the disease.3 One way to address this issue is by treating … It is hard to extricate treating the underlying disease from treating the disability. … Conversely, does treating pneumonia differ depending on whether the patient has mobility limitations … Or does treating a urinary infection differ for a person with quadriplegia compared with someone without … Outcomes for quality medical care (whether treating the disabling condition or treating the disability

103. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating … Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating … focusing on long-term benefits and harms of ACEIs versus ARBs versus direct renin inhibitors for treating … Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating

104. Evidence Summary_Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer: A Realist Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/models-care-adult-survivors-childhood-cancer-evidence-summary.pdf
     February 01, 2022 - versus primary care, survivor and provider knowledge (e.g., survivor risks and needs), provider comfort treating … primary care, survivor and provider knowledge (i.e., survivor risks and needs), provider comfort treating

105. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - Treating CDI, active control: Probiotics, prebiotics, C. difficile immune whey, and colestipol are not … is effective in treating recurrent CDI for up to 1 year. … Treating CDI, active control: Probiotics, prebiotics, C. difficile immune whey, and colestipol are … is effective in treating recurrent CDI for up to 1 year. … is effective in treating recurrent CDI for up to 1 year.

106. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
     February 01, 2016 - . �� Evidence related to the effectiveness of medications for treating patients with AUD in primary … To Discuss With Your Patients and/or Their Caregivers �� The medications currently available for treating … caregivers talk with their health care professionals about the various medications that are available for treating

107. Topic 0610 CE of Treatments for Uterine Fibroids NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0745-141009.pdf
     September 03, 2014 - provided insurance have clinically significant uterine fibroids, and the direct costs associated with treating

108. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - offer a long- lasting, single-injection pharmacotherapy alternative to laser photocoagulation for treating … FDA approved once- weekly exenatide in January 2012 for treating T2DM. … New advances in devices, pharmacotherapies, and surgical techniques have shown promise in treating … While some experts agreed that any new therapy for treating diabetes would be welcome, this form of … New advances in pharmacotherapy and surgical techniques have shown promise in treating DME. 30

109. For patients with PKU, there is now a pharmaceutical drug to treat this condition. In the past is was treated by medical foods that eliminated the harmful substance phenylalanine. The cost of the new drug is $70K year. The cost to treat… | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-t

110. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Administration (FDA) regulatory submissions for lesinurad (200 mg) as a once-daily combination therapy for treating … marketing, lesinurad would be covered by third-party payers similar to other uric acid–lowering drugs for treating … preparing regulatory submissions for lesinurad (200 mg) as a once-daily chronic combination therapy for treating … lesinurad will probably be covered by third-party payers similarly to other uric acid-lowering drugs for treating … Rate of serum uric acid (SUA) assessment in gout patients treated with urate-lowering therapy: treating

111. Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update

112. Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research

113. Siminoff_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
     January 01, 2012 - .”  The most common concern of physicians treating diabetes is “renal  failure.” … Alternative treatments o Treatment decisions  Surgery  Radiation  Chemotherapy  Pain Medication   o Treating

114. Binge-Eating Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
     December 01, 2015 - Current Challenges and Controversies in Treating These Disorders Treating patients with BED targets … Recently, lisdexamfetamine became the first medication approved by the FDA for treating BED patients … Harms associated with treating BED patients and discontinuations from studies attributable to harms … The evidence base about treating LOC eating was small for children and nonexistent for bariatric surgery … Only lisdexamfetamine has FDA approval for treating BED (presumably taking both benefits and adverse

115. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Food and Drug Administration (FDA) in February ES-4 2012 for treating RRMS. … In May 2011, FDA approved Nasha/Dx for treating fecal incontinence in adult patients whose disease … In August 2011, MAP Pharmaceuticals filed an NDA for Levadex for treating migraine headache, and FDA … One expert with a clinical background stated, “OBI-1 is a unique alternative to treating inhibitors … Efficacy and tolerability of MAP0004, a novel inhaled therapy, in treating acute migraine.

116. Management and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
     May 01, 2016 - Evidence on the effectiveness of CBT, BWL, and other types of psychological or behavioral therapy in treating … preferences and factors that may impact access to or adherence to treatment Resource for Patients Treating … Ordering Information For electronic copies of Treating Binge-Eating Disorder: A Review of the Research

117. Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_clinician.pdf
     September 01, 2016 - nonpharmacological and pharmacological treatment options are available for MDD �� The risks associated with not treating … or ineffectively treating MDD, such as worsening or persisting depression and suicide �� That treatment

118. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - In June 2011, FDA approved fidaxomicin for treating C. difficile-associated diarrhea. … Patients with long-term CDI recurrence, as well as their treating physicians, might be eager to try … In addition, experts had some concern that treating patients with vancomycin for CDI might make them … /Cancer/AnalCancer/DetailedGuide/anal-cancer-treating-general-info https://integrity.prous.com/ http: … Treating clostridium difficile infection with fecal microbiota transplantation.

119. S96 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
     October 01, 2007 - A case in NEISS-CADES is defined as an ED visit for a condition that the treating physician explicitly … intentional self-harm, drug therapeutic failures, recreational drug use, or drugs administered in the treating … Furthermore, because ADE identification in NEISS- CADES is based on the treating physician’s clinical … Third, ADEs may not be identified by NEISS-CADES unless the treating physician recognizes an association … Documentation of ADEs in the medical record may be subject to the treating clinician’s medical training

120. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
     August 05, 2010 - A challenge in treating osteoarthritis is deciding which medications will provide the greatest symptom … Since the completion of the original report, three topical NSAIDs have received FDA approval for treating … What are the comparative benefits and harms of treating osteoarthritis with oral medications or supplements … associated with the use of nonsteroidal antiinflammatory drugs (NSAIDs) includes studies of these drugs for treating … Question 4 What are the comparative benefits and harms of treating osteoarthritis with oral medications